In case you missed it, on Monday MIT announced that they would be reinstating their SAT/ACT requirement for future admissions cycles. Like many universities, MIT had ditched the tests during the pandemic.
Even prior to the pandemic, however, there had been a widespread push to abandon these tests to enhance diversity.
“Data shows tests like the SAT are biased against students from low-income households. Poorer students tend to perform worse on the test,” CNN reported in 2015. “Blacks and Hispanics also consistently score lower on the SAT than whites.” (CNN conveniently left out that Asian Americans score much higher than whites, presumably because it didn’t fit the narrative.)
The American Bar Association House of Delegates has approved new law school accreditation standards at the 2022 ABA Midyear Meeting, of which two amendments were focused on “diversity.”
In order to eliminate bias and enhance diversity, the ABA’s amended Standard 303(c) requires that “a law school shall provide education on bias, cross-cultural competency, and racism: (1) at the start of the program of legal education, and (2) at least once again before graduation.”
To fulfill this requirement, “Law schools must demonstrate that all law students are required to participate in a substantial activity designed to reinforce the skill of cultural competency and their obligation as future lawyers to work to eliminate racism in the legal profession.”
Stanford University has made its admissions process test-optional for the third year in a row.
Following the arrival of COVID-19 in the United States, Stanford previously suspended standardized testing requirements for the 2020-21 undergraduate admissions cycle. Stanford School of Medicine ceased requiring the Medical College Admission Test (MCAT), and physics graduate applicants did not have to submit scores for the Graduate Record Examinations (GRE) or the GRE subject test in physics.
Now, according to the university’s admissions site: “For both the current 2021-22 admission cycle and the following 2022-23 cycle,Stanford will not require ACT or SAT scores for first-year or transfer applicants.
U.S. drug agents are expanding operations in China – six years after America’s largest trading partner and global rival emerged as the main source of chemicals used to make highly lethal fentanyl. It’s now claiming 65,000 American lives a year.
The small crew of about a dozen Drug Enforcement Administration agents, including those in new outposts in Shanghai and Guangzhou, is nearly double the number in 2018. They face what seems like mission impossible: collaborating with Chinese agents to try to bust traffickers hidden somewhere in a sprawling export supply chain that’s linked to 160,000 companies.
“It’s such a massive chemical industry, and then there are layer upon layer of traders, brokers and freight forwarders,” says Russ Holske, the DEA’s director for the Far East, who set up the new offices in China before he retired. “It’s a daunting challenge.”